Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy

Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy

Background We aimed to assess the impact of genomic human leukocyte antigen (HLA)-I/II homozygosity on the survival benefit of patients with unresectable locally advanced, metastatic non-small lung cancer treated by single-agent programmed cell death protein-1/programmed death ligand 1 (PD1/PDL1) in...

Full description

Bibliographic Details
Main Authors: Mark Watson, Michael Millward, Samantha Bowyer, Afaf Abed, Leslie Calapre, Johnny Lo, Suzana Correia, Abha Chopra, Muhammad Adnan Khattak, Elin Solomonovna Gray
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001620.full

Internet

https://jitc.bmj.com/content/8/2/e001620.full

Similar Items